Pith. sign in

REVIEW 4 major objections 36 references

ReachVox: Clutter-free Reachability Visualization for Robot Motion Planning in Virtual Reality

T0 review · 4 major / 0 minor · reviewed 2026-08-05 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

Pith's one-line read ReachVox, a minimalistic voxel-based encoding of robot arm reachability near an object of interest, helps remote operators collaborate with a robot arm in VR better than a point-based reachability check.

desk verdict The submitted full text is an unrelated antibody-design paper, so the n=20 user study that ReachVox's central claim rests on is entirely absent; as submitted, this is unreviewable. read the letter →

arxiv 2508.11426 v1 pith:63FC222G submitted 2025-08-15 cs.HC cs.RO

Steffen Hauck , Diar Abdlkarim , John Dudley , Per Ola Kristensson , Eyal Ofek , Jens Grubert This is my paper · ORCID
classification cs.HCcs.RO
keywords reachabilityvisualizationvirtualrealityhuman-robotcollaborationrobotmotionplanningvoxelencodingremoteoperatoruserstudyclutter-freedisplay
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

ReachVox is a virtual-reality visualization that encodes, as a minimal voxel volume, whether points near an object of interest are reachable by a robot arm. The paper asks whether this clutter-free reachability encoding improves collaboration between a remote human operator and a robot arm, compared with a point-based reachability check. The answer, from a user study with 20 participants, is that ReachVox indicates an advantage: operators using it can assess reachability and plan motions more effectively. If the finding holds, ReachVox offers a lightweight way to support human-robot collaboration in dynamic environments where paths must be constantly adapted.

What carries the argument

The central object is ReachVox itself: a voxel-based encoding of reachability that marks the space near an object of interest as reachable or not, presented as a minimal overlay in VR. It does the argument's work by turning a discrete, point-by-point reachability query into a continuous spatial field, letting the operator see at a glance where the arm can go. The point-based reachability check-up serves as the comparison baseline that the study measures against.

What would settle it

Run the same comparison with a physical robot arm in a dynamically changing scene, measuring task time and collision errors; if the voxel-based encoding does not outperform the point-based check-up—or increases errors—the central claim fails. A high-powered replication (e.g., 60+ participants) with a pre-registered outcome measure could also produce a null result that cancels the indication from n=20.

Watch

Extended reading notes

Core claim

ReachVox is a minimalistic, voxel-based visualization that shows a remote VR operator which points near an object of interest the robot arm can reach. The paper's central claim is that this encoding aids human-robot collaboration relative to a point-based reachability check-up. The claim is supported by a user study (n=20) reporting performance or subjective measures that favor ReachVox. The implication is that a spatially continuous, low-clutter reachability display can replace discrete point checks during robot motion planning, potentially reducing the operator's burden in dynamic settings.

Load-bearing premise

The whole claim rests on the assumption that a 20-person VR user study captures how remote operators would actually collaborate with a robot arm in a real dynamic environment.

Editorial extensions

If this is right

  • If ReachVox helps operators judge reachable space, it can reduce the number of discrete queries needed during robot motion planning in VR.
  • The encoding's minimalism could make reachability visible without occluding the object of interest, supporting faster decisions in dynamic environments.
  • A positive effect on collaboration would justify integrating ReachVox into VR teleoperation interfaces for robot arms.
  • The demonstration with 20 participants positions ReachVox as a candidate interface improvement, pending replication in more realistic settings.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The same voxel-reachability encoding could transfer to augmented reality overlays in physical workspaces, not just VR, since the information is inherently spatial.
  • The benefit may be largest for novice or non-expert operators who lack a mental model of the robot's kinematic limits.
  • The study's reported outcome may depend on task difficulty; a ceiling effect with trivial tasks could mask differences that appear under time pressure or with moving obstacles.
  • A natural extension is to test ReachVox with a physical robot arm and dynamic obstacles, since the abstract does not specify whether the study used simulated or real motion.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 0 minor

Summary. The paper, as represented by its abstract, proposes ReachVox, a minimalistic reachability visualization intended to aid remote operator–robot collaboration in VR. The abstract states that a user study (n=20) was conducted to indicate the strength of ReachVox relative to a point-based reachability check. The full text supplied with the submission, however, is a different manuscript (arXiv:2508.11424) on antibody sequence-structure co-design (LEAD). It contains no ReachVox, no VR system, no robot, and no user study. The submission therefore provides no inspectable evidence for the paper's central claim.

Significance. The research question is relevant to human-robot interaction and VR visualization, and a minimal clutter-free reachability encoding could be practically useful for remote operation. Comparing such an encoding against a point-based baseline is a legitimate empirical strategy. However, as submitted, the central claim is unsupported: the only evidence referenced, the n=20 user study, is not present in the full text, and the ReachVox encoding itself is never described. The paper cannot currently be evaluated for correctness, reproducibility, or transferability. The strengths that would normally be credited—a clear falsifiable comparison or a detailed study protocol—are absent because the manuscript body does not correspond to the claimed paper.

major comments (4)
  1. [Full text (entire body)] The submitted full text is a completely different manuscript on antibody design (LEAD), with no mention of ReachVox, VR, robots, or the user study. The abstract's central claim rests entirely on the n=20 user study, and that study is not described anywhere in the submission. This is a load-bearing omission: the reader cannot check the experimental design, the baseline fairness, the measured outcomes, or the statistical support for the claim.
  2. [Abstract, user-study sentence] The abstract says 'we indicate the strength of the visualization relative to a point-based reachability check-up' but reports no measures, effect sizes, or inferential statistics. The phrasing is explicitly preliminary. Even if the full text were present, this sentence would be insufficient to establish that ReachVox 'aids collaboration'; the submission would need to clarify whether the outcome was task performance, error rate, or subjective preference, and whether physical robot motion or a dynamic environment was used.
  3. [ReachVox definition (absent)] The ReachVox encoding is the core invented entity of the paper, but the full text never defines it. There are no equations, figures, or algorithmic descriptions of the encoding, how reachability is computed, or how it is rendered in VR. Without this, the central comparison cannot be reproduced or even understood.
  4. [Full text bibliographic content] The full text's references, experiments, and results all concern antibody design; there is no bibliographic or narrative connection to ReachVox. As submitted, the manuscript is not a coherent paper about the claimed topic. This is not a presentation issue but a missing-evidence problem that cannot be fixed by minor edits.

Circularity Check

1 steps flagged · score 0.0 of 10

No circular derivation; ReachVox's n=20 user study is absent from the submitted body text.

  1. other [Abstract vs supplied Full Text (body is arXiv:2508.11424, 'Generative Co-Design of Antibody Sequences and Structures...')]
    "Abstract: 'Through a user study (n=20), we indicate the strength of the visualization relative to a point-based reachability check-up.' Supplied body opens: 'Generative Co-Design of Antibody Sequences and Structures via Black-Box Guidance in a Shared Latent Space' and contains no ReachVox/VR/robotics/user study."

    The ReachVox abstract's only evidence is the n=20 user study, but the supplied full text is a different manuscript on antibody design. The claimed study is therefore not inspectable: no procedure, baseline definition, metrics, or inferential statistics are present. This is a missing-support/omitted-evidence flag per the review rule, not a circular reduction (no parameter is fitted to the outcome, no self-citation is load-bearing, and the claim is not defined in terms of the outcome).

full rationale

The ReachVox abstract contains no derivation chain, no fitted parameters, no defined-from-outcome quantities, and no self-citations; its claim is an empirical report ('Through a user study (n=20), we indicate the strength of the visualization relative to a point-based reachability check-up'). The body text supplied for inspection is an entirely different paper (LEAD, on antibody sequence-structure co-design), which shares no content with ReachVox. Per the review rule, I flag the absence of the supporting study explicitly. Missing evidence prevents verification of the central claim, but it is not circularity: the abstract does not reduce ReachVox's benefit to an input by definition, nor does it rename a known result or import a uniqueness theorem from the authors. Hence the circularity score remains 0. If the correct ReachVox paper were supplied, the empirical comparison against a point-based reachability baseline would still need to be checked for fairness (e.g., matched task time, identical robot model, and whether 'aid collaboration' was measured through performance or only subjective ratings), but that is a correctness/validity concern, not a circularity concern.

Assumptions & free parameters 0 free parameters · 2 assumptions · 1 invented entities

Based solely on the abstract of the declared ReachVox paper. The claim leans on two domain assumptions: the adequacy of a small VR user study as a proxy for real collaboration, and the fairness of the point-based baseline. No fitted numbers are identifiable. ReachVox itself is the only introduced artifact, with no independent validation.

assumptions (2)
  • domain assumption A VR user study with 20 participants is a valid proxy for real remote human-robot collaboration in dynamic environments.
    The abstract's claim that ReachVox 'can aid the collaboration' is based solely on this study; transfer of VR-measured effects to physical robot operation is assumed rather than shown.
  • domain assumption The point-based reachability check-up is a fair and representative baseline.
    The abstract compares ReachVox against 'a point-based reachability check-up' without describing its design; if the baseline was weak or mismatched, the comparison would be uninformative.
invented entities (1)
  • ReachVox encoding
    purpose: A minimalistic encoding of the reachability of a point near an object of interest, rendered in VR to aid remote operator-robot collaboration.
    Introduced by this paper; the only evidence referenced is the n=20 user study in the abstract, with no external or falsifiable validation described and no full text available.

how reviews work

0 comments
Cite this review

Pith. "Pith review of ReachVox: Clutter-free Reachability Visualization for Robot Motion Planning in Virtual Reality." pith.science (2026). https://pith.science/paper/63FC222G

@misc{pith2026250811426,
  author       = {Pith},
  title        = {Pith review of: ReachVox: Clutter-free Reachability Visualization for Robot Motion Planning in Virtual Reality},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/63FC222G}},
  note         = {Machine review of arXiv:2508.11426}
}
read the original abstract

Human-Robot-Collaboration can enhance workflows by leveraging the mutual strengths of human operators and robots. Planning and understanding robot movements remain major challenges in this domain. This problem is prevalent in dynamic environments that might need constant robot motion path adaptation. In this paper, we investigate whether a minimalistic encoding of the reachability of a point near an object of interest, which we call ReachVox, can aid the collaboration between a remote operator and a robotic arm in VR. Through a user study (n=20), we indicate the strength of the visualization relative to a point-based reachability check-up.

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

36 extracted references · 34 canonical work pages

  1. [1]

    Rosettaantibodydesign (rabd): A general frame- work for computational antibody design

    [Adolf-Bryfogle et al., 2018] Jared Adolf-Bryfogle, Oleks Kalyuzhniy, Michael Kubitz, Brian D Weitzner, Xiaozhen Hu, Yumiko Adachi, William R Schief, and Roland L Dun- brack Jr. Rosettaantibodydesign (rabd): A general frame- work for computational antibody design. PLoS computa- tional biology, 14(4):e1006112,

    work page 2018

  2. [9]

    Illuminating protein space with a programmable generative model

    [Ingraham et al., 2023] John B Ingraham, Max Baranov, Zak Costello, Karl W Barber, Wujie Wang, Ahmed Ismail, Vincent Frappier, Dana M Lord, Christopher Ng-Thow- Hing, Erik R Van Vlack, et al. Illuminating protein space with a programmable generative model. Nature, 623(7989):1070–1078,

    work page 2023

  3. [12]

    End-to-end full-atom antibody design

    [Kong et al., 2023] Xiangzhe Kong, Wenbing Huang, and Yang Liu. End-to-end full-atom antibody design. In Pro- ceedings of the 40th International Conference on Machine Learning, pages 17409–17429,

    work page 2023

  4. [13]

    Improving antibody design with force-guided sampling in diffusion models

    [Kulyt˙e et al., 2024] Paulina Kulyt ˙e, Francisco Vargas, Si- mon Valentin Mathis, Yu Guang Wang, Jos ´e Miguel Hern´andez-Lobato, and Pietro Li `o. Improving antibody design with force-guided sampling in diffusion models. arXiv preprint arXiv:2406.05832,

    arXiv 2024

  5. [14]

    A simple method for displaying the hydropathic character of a protein

    [Kyte and Doolittle, 1982] Jack Kyte and Russell F Doolit- tle. A simple method for displaying the hydropathic character of a protein. Journal of molecular biology , 157(1):105–132,

    work page 1982

  6. [17]

    Degiacomi, and Chris G

    [Leach et al., 2022] Adam Leach, Sebastian M Schmon, Matteo T. Degiacomi, and Chris G. Willcocks. Denois- ing diffusion probabilistic models on SO(3) for rotational alignment. In ICLR 2022 Workshop on Geometrical and Topological Representation Learning,

    work page 2022

  7. [18]

    Multistate and functional protein design using rosettafold sequence space diffusion

    [Lisanza et al., 2024] Sidney Lyayuga Lisanza, Jacob Merle Gershon, Samuel WK Tipps, Jeremiah Nelson Sims, Lu- cas Arnoldt, Samuel J Hendel, Miriam K Simma, Ge Liu, Muna Yase, Hongwei Wu, et al. Multistate and functional protein design using rosettafold sequence space diffusion. Nature biotechnology, pages 1–11,

    work page 2024

  8. [19]

    Antigen-specific antibody design and optimization with diffusion-based generative models for protein structures.Advances in Neu- ral Information Processing Systems, 35:9754–9767,

    [Luo et al., 2022] Shitong Luo, Yufeng Su, Xingang Peng, Sheng Wang, Jian Peng, and Jianzhu Ma. Antigen-specific antibody design and optimization with diffusion-based generative models for protein structures.Advances in Neu- ral Information Processing Systems, 35:9754–9767,

    work page 2022

Show all 36 references
  1. [20]

    Abdiffuser: full-atom generation of in-vitro functioning antibodies

    [Martinkus et al., 2024] Karolis Martinkus, Jan Ludwiczak, Wei-Ching Liang, Julien Lafrance-Vanasse, Isidro Hotzel, Arvind Rajpal, Yan Wu, Kyunghyun Cho, Richard Bon- neau, Vladimir Gligorijevic, et al. Abdiffuser: full-atom generation of in-vitro functioning antibodies. Advan...

    2024

  2. [21]

    Random gradient-free minimization of convex functions

    [Nesterov and Spokoiny, 2017] Yurii Nesterov and Vladimir Spokoiny. Random gradient-free minimization of convex functions. Foundations of Computational Mathematics , 17(2):527–566,

    2017

  3. [25]

    Iglm: Infilling language modeling for an- tibody sequence design

    [Shuai et al., 2023] Richard W Shuai, Jeffrey A Ruffolo, and Jeffrey J Gray. Iglm: Infilling language modeling for an- tibody sequence design. Cell Systems , 14(11):979–989,

    2023

  4. [26]

    Denoising diffusion implicit models

    [Song et al., 2020] Jiaming Song, Chenlin Meng, and Ste- fano Ermon. Denoising diffusion implicit models. arXiv preprint arXiv:2010.02502,

    2020 arXiv

  5. [27]

    Improving protein expression, stability, and function with proteinmpnn.Jour- nal of the American Chemical Society, 146(3):2054–2061,

    [Sumida et al., 2024] Kiera H Sumida, Reyes N ´u˜nez- Franco, Indrek Kalvet, Samuel J Pellock, Basile IM Wicky, Lukas F Milles, Justas Dauparas, Jue Wang, Yakov Kipnis, Noel Jameson, et al. Improving protein expression, stability, and function with proteinmpnn.Jour- nal of the...

    2024

  6. [28]

    Uniref: comprehensive and non-redundant uniprot reference clus- ters

    [Suzek et al., 2007] Baris E Suzek, Hongzhan Huang, Peter McGarvey, Raja Mazumder, and Cathy H Wu. Uniref: comprehensive and non-redundant uniprot reference clus- ters. Bioinformatics, 23(10):1282–1288,

    2007

  7. [30]

    Exploring log-likelihood scores for ranking an- tibody sequence designs

    [Ucar et al., 2024b] Talip Ucar, Cedric Malherbe, and Ferran Gonzalez. Exploring log-likelihood scores for ranking an- tibody sequence designs. In NeurIPS 2024 Workshop on AI for New Drug Modalities,

    2024

  8. [31]

    Weber, and Marcel J

    [Villegas-Morcillo et al., 2024] Amelia Villegas-Morcillo, Jana M. Weber, and Marcel J. T. Reinders. Guiding diffusion models for antibody sequence and structure co-design with developability properties. PRX Life , 2:033012, Sep

    2024

  9. [32]

    Optimizing antibody affinity and stability by the automated design of the variable light- heavy chain interfaces

    [Warszawski et al., 2019] Shira Warszawski, Aliza Boren- stein Katz, Rosalie Lipsh, Lev Khmelnitsky, Gili Ben Nis- san, Gabriel Javitt, Orly Dym, Tamar Unger, Orli Knop, Shira Albeck, et al. Optimizing antibody affinity and stability by the automated design of the variable lig...

    2019

  10. [34]

    Natural evolution strategies

    [Wierstra et al., 2014] Daan Wierstra, Tom Schaul, Tobias Glasmachers, Yi Sun, Jan Peters, and J ¨urgen Schmidhu- ber. Natural evolution strategies. The Journal of Machine Learning Research, 15(1):949–980,

    2014

  11. [35]

    Repurposing alphafold3-like protein folding models for antibody sequence and structure co-design

    [Yang et al., 2025] Nianzu Yang, Jian Ma, Songlin Jiang, Huaijin Wu, Shuangjia Zheng, Wengong Jin, and Junchi Yan. Repurposing alphafold3-like protein folding models for antibody sequence and structure co-design. In ICLR 2025 Workshop on Generative and Experimental Perspec- ti...

    2025

  12. [1982]

    Abdesign: A n algorithm for combinatorial backbone design guided by natural conformations and sequences

    [Lapidoth et al., 2015] Gideon D Lapidoth, Dror Baran, Gabriele M Pszolla, Christoffer Norn, Assaf Alon, Michael D Tyka, and Sarel J Fleishman. Abdesign: A n algorithm for combinatorial backbone design guided by natural conformations and sequences. Proteins: Structure, Functio...

    2015

  13. [1992]

    Antibody de- sign using lstm based deep generative model from phage display library for affinity maturation

    [Saka et al., 2021] Koichiro Saka, Taro Kakuzaki, Shoichi Metsugi, Daiki Kashiwagi, Kenji Yoshida, Manabu Wada, Hiroyuki Tsunoda, and Reiji Teramoto. Antibody de- sign using lstm based deep generative model from phage display library for affinity maturation. Scientific reports...

    2021

  14. [2001]

    Jaakkola

    [Jin et al., 2022] Wengong Jin, Jeremy Wohlwend, Regina Barzilay, and Tommi S. Jaakkola. Iterative refinement graph neural network for antibody sequence-structure co- design. In International Conference on Learning Repre- sentations,

    2022

  15. [2003]

    Protein design with guided discrete diffusion

    [Gruver et al., 2024] Nate Gruver, Samuel Stanton, Nathan Frey, Tim GJ Rudner, Isidro Hotzel, Julien Lafrance- Vanasse, Arvind Rajpal, Kyunghyun Cho, and Andrew G Wilson. Protein design with guided discrete diffusion. Advances in neural information processing systems , 36,

    2024

  16. [2007]

    Benchmarking generative models for antibody design & exploring log-likelihood for sequence ranking

    [Uc ¸aret al., 2024a] Talip Uc ¸ar, Cedric Malherbe, and Ferran Gonzalez. Benchmarking generative models for antibody design & exploring log-likelihood for sequence ranking. bioRxiv, pages 2024–10,

    2024

  17. [2012]

    Structurally resolved sars-cov-2 antibody shows high efficacy in severely infected hamsters and pro- vides a potent cocktail pairing strategy.Cell, 183(4):1013– 1023.e13, November

    [Du et al., 2020] Shuo Du, Yunlong Cao, Qinyu Zhu, Pin Yu, Feifei Qi, Guopeng Wang, Xiaoxia Du, Linlin Bao, Wei Deng, et al. Structurally resolved sars-cov-2 antibody shows high efficacy in severely infected hamsters and pro- vides a potent cocktail pairing strategy.Cell, 183(...

    2020

  18. [2014]

    Protgpt2 is a deep unsupervised lan- guage model for protein design

    [Ferruz et al., 2022] Noelia Ferruz, Steffen Schmidt, and Birte H ¨ocker. Protgpt2 is a deep unsupervised lan- guage model for protein design. Nature communications, 13(1):4348,

    2022

  19. [2015]

    Construction of a rationally designed antibody platform for sequencing- assisted selection

    [Larman et al., 2012] H Benjamin Larman, George Jing Xu, Natalya N Pavlova, and Stephen J Elledge. Construction of a rationally designed antibody platform for sequencing- assisted selection. Proceedings of the National Academy of Sciences, 109(45):18523–18528,

    2012

  20. [2017]

    Antibody engineering

    [Presta, 1992] Leonard G Presta. Antibody engineering. Current Opinion in Structural Biology , 2(4):593–596,

    1992

  21. [2018]

    Introduction to protein structure

    [Branden and Tooze, 2012] Carl Ivar Branden and John Tooze. Introduction to protein structure. Garland Science,

    2012

  22. [2019]

    De novo design of protein structure and function with rfdiffusion

    [Watson et al., 2023] Joseph L Watson, David Juergens, Nathaniel R Bennett, Brian L Trippe, Jason Yim, He- len E Eisenach, Woody Ahern, Andrew J Borst, Robert J Ragotte, Lukas F Milles, et al. De novo design of protein structure and function with rfdiffusion. Nature, 620(7976)...

    2023

  23. [2020]

    Sabdab: the structural antibody database

    [Dunbar et al., 2014] James Dunbar, Konrad Krawczyk, Jin- woo Leem, Terry Baker, Angelika Fuchs, Guy Georges, Jiye Shi, and Charlotte M Deane. Sabdab: the structural antibody database. Nucleic acids research , 42(D1):D1140–D1146,

    2014

  24. [2021]

    Deep learning guided op- timization of human antibody against sars-cov-2 variants with broad neutralization

    [Shan et al., 2022] Sisi Shan, Shitong Luo, Ziqing Yang, Junxian Hong, Yufeng Su, Fan Ding, Lili Fu, Chenyu Li, Peng Chen, Jianzhu Ma, et al. Deep learning guided op- timization of human antibody against sars-cov-2 variants with broad neutralization. Proceedings of the Nationa...

    2022

  25. [2022]

    Com- puting exponentials of skew-symmetric matrices and log- arithms of orthogonal matrices

    [Gallier and Xu, 2003] Jean Gallier and Dianna Xu. Com- puting exponentials of skew-symmetric matrices and log- arithms of orthogonal matrices. International Journal of Robotics and Automation, 18(1):10–20,

    2003

  26. [2023]

    Immunobiology: the im- mune system in health and disease , volume

    [Janeway et al., 2001] Charles Janeway, Paul Travers, Mark Walport, Mark Shlomchik, et al. Immunobiology: the im- mune system in health and disease , volume

    2001

  27. [2024]

    Denoising diffusion probabilistic models

    [Ho et al., 2020] Jonathan Ho, Ajay Jain, and Pieter Abbeel. Denoising diffusion probabilistic models. Advances in neural information processing systems , 33:6840–6851,

    2020

  28. [2025]

    Antigen-specific antibody design via direct energy-based preference optimization

    [Zhou et al., 2024] Xiangxin Zhou, Dongyu Xue, Ruizhe Chen, Zaixiang Zheng, Liang Wang, and Quanquan Gu. Antigen-specific antibody design via direct energy-based preference optimization. arXiv preprint arXiv:2403.16576, 2024

    2024 arXiv

Pith tools

Reviewed August 5, 2026 · model on record in the stance chip above.